Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$2.85 - $5.18 $1.25 Million - $2.28 Million
439,300 New
439,300 $1.44 Million
Q2 2022

Aug 12, 2022

SELL
$4.69 - $9.84 $563,269 - $1.18 Million
-120,100 Reduced 30.85%
269,253 $2.1 Million
Q1 2022

May 13, 2022

SELL
$8.44 - $16.89 $569,801 - $1.14 Million
-67,512 Reduced 14.78%
389,353 $3.62 Million
Q4 2021

Feb 11, 2022

BUY
$14.7 - $19.89 $6.72 Million - $9.09 Million
456,865 New
456,865 $7.2 Million

Others Institutions Holding ATRA

About Atara Biotherapeutics, Inc.


  • Ticker ATRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,362,304
  • Market Cap $720M
  • Description
  • Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...
More about ATRA
Track This Portfolio

Track M28 Capital Management LP Portfolio

Follow M28 Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M28 Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on M28 Capital Management LP with notifications on news.